Using more-specific 'genetic scissors' may avoid problems associated with gene editing
Thursday, March 21, 2019 - 10:30
in Health & Medicine
Recent studies have suggested a potential barrier to making CRISPR gene-editing treatments a viable option for inherited blood-related disorders such as sickle cell anemia, thalassemia, and primary immunodeficiency syndromes. Stem cells may respond to having their genes edited by shutting down—and trying to get around this roadblock could increase the risk of cancer.